Kewei Xu
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Urology top 2%
- Cancer Research top 10%
- Topics
- Bladder and Urothelial Cancer Treatments (18 papers)Pediatric Urology and Nephrology Studies (15 papers)Kidney Stones and Urolithiasis Treatments (12 papers)
- Journals
- Proceedings of the National Academy of SciencesPLoS ONEBiochemical and Biophysical Research Communications
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Kewei Xu
79 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Surgery 570
- Pulmonary and Respiratory Medicine 511
- Molecular Biology 403
- Urology 259
- Cancer Research 241
Countries citing papers authored by Kewei Xu
This map shows the geographic impact of Kewei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Xu more than expected).
Fields of papers citing papers by Kewei Xu
This network shows the impact of papers produced by Kewei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Xu. The network helps show where Kewei Xu may publish in the future.
Co-authorship network of co-authors of Kewei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Xu. A scholar is included among the top collaborators of Kewei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Xu. Kewei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 15 | |
| 9 | 31 | |
| 10 | 8 | |
| 11 | 14 | |
| 12 | 49 | |
| 13 | 50 | |
| 14 | 3 | |
| 15 | 97 | |
| 16 | 12 | |
| 17 | [Inhibition and significance of pigment epithelium-derived factor in the development and metastasis of prostate cancer]. | 3 |
| 18 | 7 | |
| 19 | 68 | |
| 20 | 13 |
About Kewei Xu
Kewei Xu is a scholar working on Urology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 88 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (18 papers), Pediatric Urology and Nephrology Studies (15 papers) and Kidney Stones and Urolithiasis Treatments (12 papers). The work is most often cited by research in Urology (259 citations), Cancer Research (241 citations) and Pulmonary and Respiratory Medicine (511 citations). Kewei Xu has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Tianxin Lin, Jian Huang, Hai Huang, Xinxiang Fan, H. Rubin, Liangkuan Bi, Wen Dong, Kuiqing Li, Kaiwen Li and Zi Yin. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.